Loading [Contrib]/a11y/accessibility-menu.js
Skip to main content
null
Clinical Hematology International
  • Menu
  • Articles
    • Case Report
    • Case study
    • Correspondence
    • Editorial
    • General
    • Original Research Articles
    • Perspective Article
    • Research Articles
    • Retrospective study
    • Review Articles
    • Survey
    • Systematic Reviews
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Blog
  • Conference-Event-Webinar
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

https://chi.scholasticahq.com/feed
General
Vol. 4, Issue 3, 2022July 08, 2022 BST

The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities

Rose Ellard, Michelle Kenyon, Daphna Hutt, Erik Aerts, Maaike de Ruijter, Christian Chabannon, Mohamad Mohty, Silvia Montoto, Elisabeth Wallhult, John Murray,
CAR-TCAR-T therapyCellular therapyImmunotherapyNursingNursing education
https://doi.org/10.1007/s44228-022-00004-8
Clinical Hematology International
Ellard, Rose, Michelle Kenyon, Daphna Hutt, Erik Aerts, Maaike de Ruijter, Christian Chabannon, Mohamad Mohty, Silvia Montoto, Elisabeth Wallhult, and John Murray. 2022. “The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities.” Clinical Hematology International 4 (3): 75–88. https:/​/​doi.org/​10.1007/​s44228-022-00004-8.
Save article as...▾

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system